Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
AHRR
REST API REST API
Homo sapiens
AHRR is differentially expressed in 153 experiments: 67 organism parts: cerebellum, lung, ... (65 more);, 49 disease states: normal, adrenocortical carcinoma, ... (47 more);, 61 cell types 296 cell lines 22 compound treatments and 41 other conditions.
Synonyms AHH, KIAA1234, AHHR, bHLHe77
Orthologs AHRR (Gallus gallus)   Ahrr (Mus musculus)   Ahrr (Rattus norvegicus)   ahrrb (Danio rerio)   AHRR (Bos taurus)   ahrr (Xenopus laevis)   AHRR (Canis familiaris)   (Compare orthologs)
Gene Ontology Term DNA binding, regulation of transcription, DNA-dependent, cytoplasm, signal transducer activity, nucleus, negative regulation of transcription from RNA polymerase II promoter, signal transduction, positive regulation of protein sumoylation
InterPro Term PAS, PAS_fold, HLH_DNA-bd
UniProt Accession A9YTQ3, D6RE68, D6RF73, E5RFG4, E5RGQ2
Search EB-eye ENSG00000063438
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-AFMX-6, ... (12 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, E-MEXP-2197, E-MEXP-903, ... (19 experiments)

Factor Value U/D Experiments
HL-60
2
E-MTAB-37, E-GEOD-24147
K562
2
E-MTAB-37, E-GEOD-24147
RPMI 8226
1
E-MEXP-921
HEL9217
1
E-MTAB-37
HEC1B
1
E-MTAB-37
differentiated
1
E-GEOD-1657
290 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-GEOD-19069, E-GEOD-20193, E-GEOD-20033, ... (22 experiments)

Factor Value U/D Experiments
induced pluripotent stem cell
2
E-GEOD-18265, E-GEOD-18147
endothelial cell
2
E-GEOD-19240, E-GEOD-3998
stromal cell
2
E-MEXP-2034, E-GEOD-1460
human embryonic stem cell
1
2
E-GEOD-20033, E-GEOD-18265, E-GEOD-18147
HLA-DR positive T-cell
1
E-GEOD-6338
vascular smooth muscle cell
1
E-TABM-130
55 more value(s).


Disease state

studied in E-GEOD-3307, E-MEXP-1072, E-MEXP-882, E-TABM-666, E-GEOD-21912, ... (22 experiments)

Factor Value U/D Experiments
adrenocortical carcinoma
2
E-GEOD-10927, E-TABM-311
Severe
1
E-GEOD-22148
plasma cell myeloma
1
E-MTAB-37
breast carcinoma
1
E-MEXP-882
poliovirus-infected
1
E-MEXP-1072
ovarian carcinoma
1
E-MTAB-37
43 more value(s).


Compound treatment

studied in E-TABM-782, E-TABM-868, E-GEOD-15811, E-GEOD-5099, E-MEXP-1958, ... (13 experiments)

Factor Value U/D Experiments
poly(I:C)
1
E-MEXP-1230
TTA
1
E-MEXP-2590
mannitol
1
E-GEOD-6400
CNOT7+CNOT8
1
E-MEXP-2218
BCR/ABL1
1
E-GEOD-15811
ultrafine particles
1
E-GEOD-4567
16 more value(s).


Age at diagnosis

studied in E-GEOD-21653

Factor Value U/D Experiments
85
1
1
E-GEOD-21653


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-TABM-325, E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-5372, E-GEOD-21589, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MEXP-2359, E-GEOD-2666, E-MEXP-2283 ... (5 experiments)

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-21138

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, ... (8 experiments)

Genotype
studied in E-GEOD-22056, E-GEOD-17476, E-TABM-868, E-TABM-601

Growth condition
studied in E-MEXP-2657, E-GEOD-12773, E-GEOD-20504, E-GEOD-19018, E-GEOD-9764, ... (8 experiments)

Histology
studied in E-TABM-234

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-1290, E-GEOD-19330, E-MEXP-1648, ... (17 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561

Localisation of metastases
studied in E-GEOD-22541

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-1657, E-GEOD-1460, E-GEOD-17636

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-10896

RNAi
studied in E-MEXP-1857, E-MEXP-1315, E-MEXP-2759

sample status
studied in E-GEOD-30573

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-19069

Stimulation
studied in E-GEOD-23984

Stimulus or stress
studied in E-GEOD-7538

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Treatment
studied in E-MEXP-973, E-GEOD-19246, E-GEOD-12198

Processing time: 0.276 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM